There were two cases (3% incidence) of herpes zoster reactivation while on acyclovir prophylaxis in one study; both cases occurred after day 30 post-CAR T-cell infusion in patients who had received CD19 CAR T cells for DLBCL (11). This evidence concerns the gene CD19 and diffuse large B-cell lymphoma.